An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome

10.1136/gut.52.5.671

Saved in:

Bibliographic Details
Main Authors:	Wagner, A., Kellow, J., Lee, O.Y., Chang, F.Y., Thongsawat, S., Mazlam, M.Z., Yuen, H., Gwee, K.A., Bak, Y.T., Jones, J.
Other Authors:	MEDICINE
Format:	Article
Published:	2014
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/117556
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-117556
record_format	dspace
spelling	sg-nus-scholar.10635-1175562023-10-26T09:10:01Z An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome Wagner, A. Kellow, J. Lee, O.Y. Chang, F.Y. Thongsawat, S. Mazlam, M.Z. Yuen, H. Gwee, K.A. Bak, Y.T. Jones, J. MEDICINE 10.1136/gut.52.5.671 Gut 52 5 671-676 GUTTA 2014-12-17T08:54:23Z 2014-12-17T08:54:23Z 2003 Article Wagner, A., Kellow, J., Lee, O.Y., Chang, F.Y., Thongsawat, S., Mazlam, M.Z., Yuen, H., Gwee, K.A., Bak, Y.T., Jones, J. (2003). An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome. Gut 52 (5) : 671-676. ScholarBank@NUS Repository. https://doi.org/10.1136/gut.52.5.671 00175749 http://scholarbank.nus.edu.sg/handle/10635/117556 000182176300012 Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
description	10.1136/gut.52.5.671
author2	MEDICINE
author_facet	MEDICINE Wagner, A. Kellow, J. Lee, O.Y. Chang, F.Y. Thongsawat, S. Mazlam, M.Z. Yuen, H. Gwee, K.A. Bak, Y.T. Jones, J.
format	Article
author	Wagner, A. Kellow, J. Lee, O.Y. Chang, F.Y. Thongsawat, S. Mazlam, M.Z. Yuen, H. Gwee, K.A. Bak, Y.T. Jones, J.
spellingShingle	Wagner, A. Kellow, J. Lee, O.Y. Chang, F.Y. Thongsawat, S. Mazlam, M.Z. Yuen, H. Gwee, K.A. Bak, Y.T. Jones, J. An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome
author_sort	Wagner, A.
title	An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome
title_short	An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome
title_full	An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome
title_fullStr	An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome
title_full_unstemmed	An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome
title_sort	asia-pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome
publishDate	2014
url	http://scholarbank.nus.edu.sg/handle/10635/117556
_version_	1781789625218498560

An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome

Similar Items